These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6673031)

  • 61. Hyperviscosity and thrombotic changes in idiopathic and secondary Raynaud's syndrome.
    Blunt RJ; George AJ; Hurlow RA; Strachan CJ; Stuart J
    Br J Haematol; 1980 Aug; 45(4):651-8. PubMed ID: 6775675
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon.
    Lau CS; McLaren M; Mackay I; Belch JJ
    Ann Rheum Dis; 1993 Jun; 52(6):443-8. PubMed ID: 8323396
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Hemorheological alterations in hypertensive patients].
    Foresto P; D'Arrigo M; Filippini F; Gallo R; Barberena L; Racca L; Valverde J; Rasia RJ
    Medicina (B Aires); 2005; 65(2):121-5. PubMed ID: 16075805
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Scleroderma, pulmonary hypertension and Raynaud's syndrome].
    Duclós F; Bohórquez A; Zambrano A; Armenta J
    Rev Esp Cardiol; 1968 Apr; 21(2):223-33. PubMed ID: 5739705
    [No Abstract]   [Full Text] [Related]  

  • 65. Scleroderma, the heart and myocardial Raynaud's phenomenon.
    Nath AR; Mehta PJ
    J Assoc Physicians India; 1993 Oct; 41(10):631-2. PubMed ID: 8294319
    [No Abstract]   [Full Text] [Related]  

  • 66. [Hemorheologic study of different forms of vasomotor acrosyndromes].
    Sarrat P; Serise JM; Freyburger G; Lorient-Roudaut MF; Boisseau MR
    J Mal Vasc; 1987; 12(1):113-6. PubMed ID: 3559405
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Raynaud's phenomenon and scleroderma; a case report and psychodynamic formulation.
    RICHARDSON HB
    Psychoanal Rev; 1955 Jan; 42(1):24-38. PubMed ID: 14371880
    [No Abstract]   [Full Text] [Related]  

  • 68. [Various plasma components and whole blood viscosity in patients with the vascular form of vibration disease].
    Turczyński B; Sroczyński J; Wegiel A
    Med Pr; 1985; 36(5):303-8. PubMed ID: 3831700
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension.
    Wigley FM
    Curr Opin Rheumatol; 1996 Nov; 8(6):561-8. PubMed ID: 9018460
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Hemorrheological factors in the developmental stages of peripheral arterial occlusive diseases].
    Artale F; Sergio G; Cramarossa L; Giunti P; Francisci A; Perego MA
    Ric Clin Lab; 1983; 13 Suppl 3():411-5. PubMed ID: 6673022
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Sclerodermia: presentation of 2 cases of sclerodermia in Raynaud's syndrome].
    Kalogiannides T
    Odontiatriki; 1969; 1():34-9. PubMed ID: 5254883
    [No Abstract]   [Full Text] [Related]  

  • 73. [Temperature-dependent rheological changes of the plasma in Raynaud's phenomenon (author's transl)].
    Kono I; Kabashima T; Yamane K; Sakurai T; Kashiwagi H; Ohshima N
    Ryumachi; 1982 Apr; 22(2):125-8. PubMed ID: 7112286
    [No Abstract]   [Full Text] [Related]  

  • 74. [Influence of age factors on the rheological properties of blood in healthy subjects and those with vascular disease].
    Artale F; Sergio G; Giunti P; Francisci A; Perego MA
    Ric Clin Lab; 1983; 13 Suppl 3():431-6. PubMed ID: 6673026
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Scleroderma and Raynaud's phenomenon: current pathogenetic interpretations and clinico-therapeutic trends].
    Zelli GP; Cannata P
    Ann Ital Chir; 1981; 53(3):337-43. PubMed ID: 7337317
    [No Abstract]   [Full Text] [Related]  

  • 76. Scleroderma associated with Raynaud's disease.
    Lantz H
    J Oral Med; 1967 Jul; 22(3):103-7. PubMed ID: 5235027
    [No Abstract]   [Full Text] [Related]  

  • 77. [Raynaud's phenomenon and sclerodermia].
    Ezquerra Gadea J; López Larrayoz I; García Cores F; García Muñoz M
    Aten Primaria; 2003 Jun; 32(1):60. PubMed ID: 12812693
    [No Abstract]   [Full Text] [Related]  

  • 78. Haemorrheological effects of prostaglandin E1 infusion in Raynaud's syndrome.
    Lucas GS; Simms MH; Caldwell NM; Alexander SJ; Stuart J
    J Clin Pathol; 1984 Aug; 37(8):870-3. PubMed ID: 6540787
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Whole-blood and plasma viscosity in two cases of mixed connective tissue disease with Raynaud's phenomenon and cold agglutinemia].
    Nakazato K; Sakurai T; Kubota K; Kurabayashi H; Tamura J; Shirakura T
    Rinsho Byori; 1988 Oct; 36(10):1201-4. PubMed ID: 3246733
    [No Abstract]   [Full Text] [Related]  

  • 80. Blood viscosity and Raynaud's disease.
    Walder DN
    J R Coll Surg Edinb; 1973 Sep; 18(5):277-80. PubMed ID: 4746829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.